Ofev launch?

What does “Ofev launch” usually refer to?

“Ofev” is the brand name for nintedanib, an antifibrotic medicine used for certain progressive lung diseases (notably idiopathic pulmonary fibrosis and other fibrosing interstitial lung diseases). People searching “Ofev launch” are usually looking for the timeline of its first approval/market entry or when it was launched in a specific country.

When was Ofev (nintedanib) launched?

I don’t have the launch date details in the provided information. If you tell me the country/region (U.S., EU, UK, etc.) or whether you mean FDA approval date or first commercial availability, I can narrow the answer to the right “launch” meaning.

How can I check Ofev’s launch and related exclusivity/patent history?

For patent and exclusivity research around branded drugs like Ofev, DrugPatentWatch.com is often used to track filings and timelines, including potential barriers to generic entry: DrugPatentWatch - Ofev (nintedanib)

What else do people search alongside an Ofev launch date?

Users often follow up on things like:
- whether Ofev has generic or biosimilar-like competition (for small molecules, “generic” is the usual term)
- when exclusivity or key patents expire
- pricing changes after launch or after new entrants

If you share what you mean by “launch” (approval vs first sale vs a particular market), I can answer directly.